Topiramate: a new agent for patients with alternating hemiplegia of childhood.
Alternating hemiplegia of childhood is a rare syndrome characterized by the onset, before 18 months of age, of frequent attacks of alternating paralysis. Here we report the efficacy of topiramate in four patients with alternating hemiplegia of childhood (AHC) that did not respond to flunarizine, as well as in two newly diagnosed patients. Following treatment with topiramate, the frequency and duration of hemiplegic attacks significantly improved in all patients. Additional symptoms such as seizures, migraine, involuntary movements, autonomic symptoms, and impaired mental development also improved. Topiramate is worth trying when treating patients with AHC as a first trial, or a substitute for flunarizine once the latter agent loses effect.
Jiang
Wj
W
Department of Neurology, Qilu Hospital of Shandong University, Jinan, China.
Chi
Zf
Z
Ma
L
L
Du
Bf
B
Shang
W
W
Guo
Hz
H
Wu
W
W
D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006429:Hemiplegia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors; D000077236:Topiramate; D016896:Treatment Outcome
D000927:Anticonvulsants; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose